[미국특허]
Method of purifying RNA binding protein-RNA complexes
원문보기
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
C12N-015/10
C12Q-001/68
출원번호
US-0104581
(2013-12-12)
등록번호
US-9447454
(2016-09-20)
발명자
/ 주소
Darnell, Robert
Jensen, Kirk
Ule, Jernej
출원인 / 주소
The Rockefeller University
대리인 / 주소
DLA Piper LLP (US)
인용정보
피인용 횟수 :
0인용 특허 :
56
초록▼
The present invention provides methods for purifying RNA molecules interacting with an RNA binding protein (RBP), and the use of such methods to analyze a gene expression profile of a cell. The invention also provides sequences of RNA molecules that mediate binding to an RBP, proteins encoded by the
The present invention provides methods for purifying RNA molecules interacting with an RNA binding protein (RBP), and the use of such methods to analyze a gene expression profile of a cell. The invention also provides sequences of RNA molecules that mediate binding to an RBP, proteins encoded by the sequences, a method of identifying the sequences, and the use of the sequences in a screen to identify bioactive molecules. The invention also provides RNA motifs found among the sequences and compounds that bind the RNA motifs. In addition, the invention provides methods of treating diseases associated with a function of an RNA binding protein.
대표청구항▼
1. A method for isolating one or more test RNA molecules having one or more binding sites interacting with an RNA binding protein (RBP) of interest from a biological sample, said method comprising the steps of: (a) irradiating a test biological sample to create an irreversible covalent crosslinking
1. A method for isolating one or more test RNA molecules having one or more binding sites interacting with an RNA binding protein (RBP) of interest from a biological sample, said method comprising the steps of: (a) irradiating a test biological sample to create an irreversible covalent crosslinking between the test RNA molecules and RBPs of interest in said test biological sample, thereby generating a sample of covalently-linked RBP-test RNA complexes which is substantially absent from a control biological sample which was not subjected to irradiation, wherein the one or more test RNA molecules are not modified with a chemical group to facilitate crosslinking with the RBP prior to irradiating the test biological sample;(b) cleaving the test RNA molecules of said covalently-linked RBP-test RNA complexes by contacting said sample of covalently-linked RBP-test RNA complexes with a nuclease, thereby generating a first population of covalently-linked RBP-test RNA fragment complexes;(c) generating a second population of covalently-linked RBP-test RNA fragment complexes by selecting covalently-linked RBP-test RNA fragment complexes in said first population by utilizing a molecule that specifically interacts with a component of said covalently-linked RBP-test RNA fragment complexes in said first population;(d) purifying said second population of covalently-linked RBP-test RNA fragment complexes obtained in step (c) under stringent conditions comprising the consecutive steps of: (i) washing the complexes with buffer;(ii) boiling the complexes in a denaturing ionic detergent;(iii) separating the complexes by SDS-PAGE; and(iv) transferring said complexes to a substrate that preferentially binds test RNA covalently crosslinked to protein over test RNA not covalently crosslinked to protein;(e) digesting said RBP with a protease to liberate said fragments of test RNA from said purified second population of covalently-linked RBP-test RNA fragment complexes; and(f) amplifying said fragments of test RNA obtained in step (e),thereby isolating the one or more test RNA molecules having the one or more binding sites interacting with the RNA binding protein of interest. 2. The method of claim 1, wherein said nuclease is RNAse T1. 3. The method of claim 1, further comprising labeling said test RNA molecule. 4. The method of claim 1, wherein said substrate is a nitrocellulose membrane. 5. The method of claim 1, wherein the irradiating of the biological sample comprises the input of sufficient energy to produce at least about a 4-fold enrichment in the frequency of occurrence of the one or more RBP binding sites in the second population of covalently-linked RBP-test RNA fragment complexes as compared with the expected random occurrence of the one or more RBP binding sites. 6. The method of claim 1, wherein the irradiating of the biological sample comprises the input of sufficient energy to produce at least about a 10-fold enrichment in the frequency of occurrence of the one or more RBP binding sites in the second population of covalently-linked RBP-test RNA fragment complexes as compared with the expected random occurrence of the one or more RBP binding sites. 7. The method of claim 1, wherein the irradiating of the biological sample comprises the input of sufficient energy to produce at least about a 4-fold to an at least about a 10-fold enrichment in the frequency of occurrence of the one or more RBP binding sites in the second population of covalently-linked RBP-test RNA fragment complexes as compared with the expected random occurrence of the one or more RBP binding sites. 8. The method of claim 1, wherein the irradiating of the biological sample comprises the input of about 400 milliJoules per square centimeter of the biological sample. 9. The method of claim 1, wherein the fragments of the one or more test RNA molecules obtained in step (e) are amplified by ligating nucleotide linkers to said fragments of one or more test RNA molecules and subjecting the fragments of the one or more test RNA molecules to reverse transcriptase-polymerase chain reaction (RT-PCR). 10. The method of claim 9, wherein said nucleotide linkers are directionally oriented. 11. The method of claim 1, wherein the molecule that specifically interacts with the component of said RBP-test RNA fragment complexes is an antibody. 12. The method of claim 1, wherein the one or more binding sites on the one or more test RNA molecules interacting with an RNA binding protein of interest comprise an RNA motif which exhibits a particular structure. 13. The method of claim 12, wherein the RNA motif comprises a recurring RNA element, structure or sequence. 14. The method of claim 1, wherein the sequence of the one or more test RNA molecules interacting with an RNA binding protein of interest is determined. 15. The method of claim 1, wherein the one or more test RNA molecules interacting with an RNA binding protein of interest is subjected to RNA footprinting. 16. The method of claim 1, wherein the method is an unbiased screen. 17. The method of claim 16, wherein the one or more test RNA molecules interacting with an RNA binding protein of interest was not predetermined. 18. The method of claim 17, wherein the sequence of the one or more test RNA molecules interacting with an RNA binding protein of interest is determined. 19. The method of claim 18, wherein the fragments of the one or more test RNA molecules obtained in step (e) are amplified by ligating nucleotide linkers to said fragments of RNA and subjecting the test RNA fragments to reverse transcriptase-polymerase chain reaction (RT-PCR). 20. The method of claim 19, wherein said nucleotide linkers are directionally oriented. 21. The method of claim 1, wherein the test biological sample is selected from the group consisting of whole tissue biopsy, tissue sample biopsy and whole organ. 22. The method of claim 1, wherein the test RNA fragment is derived from a transfer RNA, a small nuclear RNA, a ribosomal RNA, a messenger RNA, an antisense RNA, a small inhibitory RNA, a micro RNA or a ribozyme.
Fodor Stephen P. A. (Palo Alto CA) Pirrung Michael C. (Durham NC) Read J. Leighton (Palo Alto CA) Stryer Lubert (Stanford CA), Array of oligonucleotides on a solid substrate.
Cronin Maureen T. ; Miyada Charles Garrett ; Hubbell Earl A. ; Chee Mark ; Fodor Stephen P. A. ; Huang Xiaohua C. ; Lipshutz Robert J. ; Lobban Peter E. ; Morris Macdonald S. ; Sheldon Edward L., Arrays of nucleic acid probes and methods of using the same for detecting cystic fibrosis.
Chee Mark ; Cronin Maureen T. ; Fodor Stephen P. A. ; Huang Xiaohua X. ; Hubbell Earl A. ; Lipshutz Robert J. ; Lobban Peter E. ; Morris MacDonald S. ; Sheldon Edward L., Arrays of nucleic acid probes on biological chips.
Metin Colpan DE; Joachim Schorr DE; Ralf Herrmann DE; Petra Feuser DE, Chromatographic purification and separation process for mixtures of nucleic acids.
Winkler James L. (Palo Alto CA) Fodor Stephen P. A. (Palo Alto CA) Buchko Christopher J. (Ann Arbor MI) Ross Debra A. (Fremont CA) Aldwin Lois (San Mateo CA) Modlin Douglas N. (Palo Alto CA), Combinatorial strategies for polymer synthesis.
Winkler James L. ; Fodor Stephen P. A. ; Buchko Christopher J. ; Ross Debra A. ; Aldwin Lois ; Modlin Douglas N., Combinatorial strategies for polymer synthesis.
Hubbell Earl A. (Mt. View CA) Lipshutz Robert J. (Palo Alto CA) Morris Macdonald S. (San Jose CA) Winkler James L. (Palo Alto CA), Computer-aided engineering system for design of sequence arrays and lithographic masks.
Hubbell Earl A. (Mt. View CA) Morris MacDonald S. (San Jose CA) Winkler James L. (Palo Alto CA), Computer-aided engineering system for design of sequence arrays and lithographic masks.
Lockhart David J. ; Brown Eugene L. ; Wong Gordon G. ; Chee Mark S. ; Gingeras Thomas R., Expression monitoring by hybridization to high density oligonucleotide arrays.
Pirrung Michael C. (Durham NC) Read J. Leighton (Palo Alto CA) Fodor Stephen P. A. (Palo Alto CA) Stryer Lubert (Stanford CA), Large scale photolithographic solid phase synthesis of an array of polymers.
Pirrung Michael C. (Durham NC) Read J. Leighton (Palo Alto CA) Fodor Stephen P. A. (Palo Alto CA) Stryer Lubert (Stanford CA), Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof.
Dichiara Robert R. (Middletown NY) Lyons Christopher F. (LaGrangeville NY) Sooriyakumaran Ratnasabapathy (Fishkill NY) Spinillo Gary T. (Wappingers Falls NY) Welsh Kevin M. (Fishkill NY) Wood Robert , Mid and deep-uv antireflection coatings and methods for use thereof.
Fodor Stephen P. A. (Palo Alto CA) Stryer Lubert (Stanford CA) Winkler James L. (Palo Alto CA) Holmes Christopher P. (Sunnyvale CA) Solas Dennis W. (San Francisco CA), Photolabile nucleoside and peptide protecting groups.
Pease R. Fabian (Stanford CA) McGall Glenn (Mountain View CA) Goldberg Martin J. (San Jose CA) Rava Richard P. (Palo Alto CA) Fodor Stephen P. A. (Palo Alto CA) Goss Virginia (Santa Barbara CA) Strye, Printing molecular library arrays using deprotection agents solely in the vapor phase.
Pease R. Fabian ; McGall Glenn ; Goldberg Martin J. ; Rava Richard P. ; Fodor Stephen P. A. ; Goss Virginia ; Stryer Lubert ; Winkler James L., Printing oligonucleotide arrays using deprotection agents solely in the vapor phase.
Mullis Kary B. (Kensington CA) Erlich Henry A. (Oakland CA) Arnheim Norman (Woodland Hills CA) Horn Glenn T. (Emeryville CA) Saiki Randall K. (Richmond CA) Scharf Stephen J. (Berkeley CA), Process for amplifying, detecting, and/or-cloning nucleic acid sequences.
Barrett Ronald W. (Sunnyvale CA) Pirrung Michael C. (Durham NC) Stryer Lubert (Stanford CA) Holmes Christopher P. (Sunnyvale CA) Sundberg Steven A. (San Francisco CA), Spatially-addressable immobilization of anti-ligands on surfaces.
Barrett Ronald W. (Sunnyvale CA) Pirrung Michael C. (Durham NC) Stryer Lubert (Stanford CA) Holmes Christopher P. (Sunnyvale CA) Sundberg Steven A. (San Francisco CA), Spatially-addressable immobilization of anti-ligands on surfaces.
Barrett Ronald W. (Sunnyvale CA) Pirrung Michael C. (Durham NC) Stryer Lubert (Stanford CA) Holmes Christopher P. (Sunnyvale CA) Sundberg Steven A. (San Francisco CA), Spatially-addressable immobilization of anti-ligands on surfaces.
McGall Glenn H. (Mountain View CA) Fodor Stephen P. A. (Palo Alto CA) Sheldon Edward L. (Menlo Park CA), Spatially-addressable immobilization of oligonucleotides and other biological polymers on surfaces.
Fodor Stephen P. A. (Palo Alto CA) Pirrung Michael C. (Durham NC) Read J. Leighton (Palo Alto CA) Stryer Lubert (Stanford CA), Synthesis and screening of immobilized oligonucleotide arrays.
Fodor Stephen P. A. (Palo Alto CA) Stryer Lubert (Stanford CA) Pirrung Michael C. (Durham NC) Read J. Leighton (Palo Alto CA), Very large scale immobilized polymer synthesis.
Winkler James L. (Palo Alto CA) Fodor Stephen P. A. (Palo Alto CA) Buchko Christopher J. (Palo Alto CA) Ross Debra A. (Fremont CA) Aldwin Lois (San Mateo CA), Very large scale immobilized polymer synthesis using mechanically directed flow paths.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.